These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36509688)

  • 1. Reasons that clinicians in Australia offer cervical screening outside guidelines for frequency, age and co-testing.
    Dodd RH; Obermair HM; McCaffery KJ
    Public Health Res Pract; 2022 Dec; 32(4):. PubMed ID: 36509688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicians' attitude towards changes in Australian National Cervical Screening Program.
    Yap D; Liang X; Garland SM; Hartley S; Gorelik A; Ogilvie G; Tan J; Wrede CDH; Jayasinghe Y
    J Clin Virol; 2016 Mar; 76 Suppl 1():S81-S87. PubMed ID: 26651602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
    Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australian National Cervical Screening Program renewal: Attitudes and experiences of general practitioners, and obstetricians and gynaecologists.
    Obermair HM; Bennett KF; Brotherton JML; Smith MA; McCaffery KJ; Dodd RH
    Aust N Z J Obstet Gynaecol; 2021 Jun; 61(3):416-423. PubMed ID: 33512715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16-28 years.
    Jayasinghe Y; Rangiah C; Gorelik A; Ogilvie G; Wark JD; Hartley S; Garland SM
    J Clin Virol; 2016 Mar; 76 Suppl 1():S74-S80. PubMed ID: 26589584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.
    Lew JB; Simms KT; Smith MA; Hall M; Kang YJ; Xu XM; Caruana M; Velentzis LS; Bessell T; Saville M; Hammond I; Canfell K
    Lancet Public Health; 2017 Feb; 2(2):e96-e107. PubMed ID: 29253402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do they cope or mope? A survey of GPs' experiences with the changes in the Norwegian Cervical Cancer Screening Programme.
    Afseth S; Bowe A; Mjølstad BP; Vie GÅ; Baasland I
    Scand J Prim Health Care; 2022 Sep; 40(3):385-394. PubMed ID: 36314584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis.
    Felix JC; Lacey MJ; Miller JD; Lenhart GM; Spitzer M; Kulkarni R
    J Womens Health (Larchmt); 2016 Jun; 25(6):606-16. PubMed ID: 27023044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of human papillomavirus self-sampling into the revised National Cervical Screening Program: a qualitative study of GP experiences and attitudes in rural New South Wales.
    Foo YM; Goswami P; Grogin J; Hargan E; Thangarajah M; Dutton T; Mendel S; Bailey J
    Aust J Prim Health; 2021 Aug; 27(4):284-290. PubMed ID: 33985644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
    Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
    Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
    Wong EL; Cheung AW; Wong AY; Chan PK
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
    [No Abstract]   [Full Text] [Related]  

  • 13. No. 385-Indications for Pelvic Examination.
    Evans D; Goldstein S; Loewy A; Altman AD
    J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine cervical screening by primary HPV testing: early findings in the renewed National Cervical Screening Program.
    Machalek DA; Roberts JM; Garland SM; Thurloe J; Richards A; Chambers I; Sivertsen T; Farnsworth A
    Med J Aust; 2019 Aug; 211(3):113-119. PubMed ID: 31168828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia.
    Canfell K; Saville M; Caruana M; Gebski V; Darlington-Brown J; Brotherton J; Heley S; Castle PE
    BMJ Open; 2018 Jan; 8(1):e016700. PubMed ID: 29374658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study.
    Gök M; Heideman DA; van Kemenade FJ; Berkhof J; Rozendaal L; Spruyt JW; Voorhorst F; Beliën JA; Babovic M; Snijders PJ; Meijer CJ
    BMJ; 2010 Mar; 340():c1040. PubMed ID: 20223872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2012 Jun; 156(12):880-91, W312. PubMed ID: 22711081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening.
    Snijders PJ; Verhoef VM; Arbyn M; Ogilvie G; Minozzi S; Banzi R; van Kemenade FJ; Heideman DA; Meijer CJ
    Int J Cancer; 2013 May; 132(10):2223-36. PubMed ID: 22907569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists.
    Perkins RB; Anderson BL; Gorin SS; Schulkin JA
    Am J Prev Med; 2013 Aug; 45(2):175-81. PubMed ID: 23867024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.